Rachel Dreilinger

Rachel Dreilinger is a biomedical engineer with 19 years of experience in engineering product development, consulting, startups, lab automation, robotics, DNA synthesis, and medical and surgical device development. She is currently Co-Founder and CEO of a neurosurgery device company, NeuraMedica Inc. managing all aspects of commercialization including business development, fundraising, IP, operations, engineering development, market research and sales & marketing. She has also run a successful engineering consultancy, Radical R&D, since 2008 specializing in medical device design for clients such as OHSU, Bayer Healthcare, Ziba Design, and Acute Innovations (a subsidiary of Acumed). She has extensive experience in orthopedics, neurosurgery, dentistry, bioabsorbable polymers, mechanical design and all phases of product development. She received her B.S. degree in Bioengineering from the University of California, San Diego (UCSD) in 1999.

Participating years: 2018, 2020